BJE-6-106

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameBJE-6-106
Drug Alias NameBJE-6-106BJE6-106
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C delta inhibitors
TargetsProtein kinase C delta
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoston University
China Registration ClassN/A

Develop Information

Active CompaniesBoston University
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A